The global urinary catheters market size was estimated at USD 6.54 billion in 2025 and is projected to reach USD 10.92 billion by 2033, growing at a CAGR of 6.69% from 2026 to 2033. The growth is attributed to the rising prevalence of urological disorders such as urinary incontinence, benign prostatic hyperplasia, and spinal cord injuries, which necessitate long-term catheterization.
The growing aging population and increasing number of surgical procedures and hospitalizations further fuel product demand. In addition, the expanding adoption of home healthcare and the rising preference for minimally invasive and non-invasive urinary management solutions, such as external and intermittent catheter, are accelerating market growth. Technological advancements, including antimicrobial coatings and silicone-based materials that enhance patient comfort and reduce infection risk, along with greater awareness among patients and caregivers about urinary management options, are expected to support the market’s expansion over the forecast period.
The rising burden of urinary incontinence is significantly driving the growth of the urinary catheters industry, as an aging population and the increasing prevalence of conditions such as stress, urgency, and mixed incontinence have expanded the patient base requiring bladder management solutions. As more individuals experience moderate to severe leakage and reduced quality of life, demand for both intermittent and indwelling catheters that provide effective, reliable urine drainage has increased. The condition is also diagnosed due to improved awareness and better screening in primary care settings, further expanding treatment uptake. In addition, the rising number of patients with neurogenic bladder disorders, diabetes-related complications, and post-surgical incontinence has strengthened long-term catheter usage.
Furthermore, the rising prevalence of benign prostatic hyperplasia is projected to significantly boost the demand for urinary catheters in the coming years. Urinary catheter are vital in managing BPH by providing immediate relief from urinary retention and improving patients’ quality of life. For individuals affected by BPH, catheters facilitate urine drainage by bypassing the obstruction caused by an enlarged prostate. Given their critical role in symptom management and patient care, the increasing incidence of BPH is expected to drive sustained growth in the industry.
The growing aging population and increasing number of surgical procedures and hospitalizations further fuel product demand. In addition, the expanding adoption of home healthcare and the rising preference for minimally invasive and non-invasive urinary management solutions, such as external and intermittent catheter, are accelerating market growth. Technological advancements, including antimicrobial coatings and silicone-based materials that enhance patient comfort and reduce infection risk, along with greater awareness among patients and caregivers about urinary management options, are expected to support the market’s expansion over the forecast period.
The rising burden of urinary incontinence is significantly driving the growth of the urinary catheters industry, as an aging population and the increasing prevalence of conditions such as stress, urgency, and mixed incontinence have expanded the patient base requiring bladder management solutions. As more individuals experience moderate to severe leakage and reduced quality of life, demand for both intermittent and indwelling catheters that provide effective, reliable urine drainage has increased. The condition is also diagnosed due to improved awareness and better screening in primary care settings, further expanding treatment uptake. In addition, the rising number of patients with neurogenic bladder disorders, diabetes-related complications, and post-surgical incontinence has strengthened long-term catheter usage.
- According to a 2025 study published by the European Association of Urology, the average age of 722 respondents was 52.6 years. The large majority were Italian citizens, and most had completed secondary education. The prevalence of urinary incontinence in this population was 44.8%, meaning that nearly one in two middle-aged women experienced some degree of leakage. Stress urinary incontinence (SUI) was the most common subtype, affecting 39.1% of respondents, followed by urgency urinary incontinence (UUI) in 13.8% and mixed urinary incontinence (MUI) in 9.1%. In terms of severity, 19.6% of participants reported mild symptoms, 20.4% reported moderate symptoms, and 4.3% reported severe or very severe leakage.
Furthermore, the rising prevalence of benign prostatic hyperplasia is projected to significantly boost the demand for urinary catheters in the coming years. Urinary catheter are vital in managing BPH by providing immediate relief from urinary retention and improving patients’ quality of life. For individuals affected by BPH, catheters facilitate urine drainage by bypassing the obstruction caused by an enlarged prostate. Given their critical role in symptom management and patient care, the increasing incidence of BPH is expected to drive sustained growth in the industry.
Urinary Catheters Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends across sub-segments from 2021 to 2033. For this study, the analyst has segmented the global urinary catheters market report based on product, application, type, gender, end use, and region:Product Outlook (Revenue, USD Million, 2021-2033)
- Intermittent Catheters
- Foley/ Indwelling Catheters
- External Catheters
Application Outlook (Revenue, USD Million, 2021-2033)
- Benign Prostate Hyperplasia
- Urinary Incontinence
- Spinal Cord Injury
- Others
Type Outlook (Revenue, USD Million, 2021-2033)
- Coated Catheters
- Uncoated Catheters
Gender Outlook (Revenue, USD Million, 2021-2033)
- Male
- Female
End Use Outlook (Revenue, USD Million, 2021-2033)
- Hospitals
- Clinics
- Long-term Care Facilities
- Others
Regional Outlook (Revenue, USD Million, 2021-2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Urinary Catheters Market Variables, Trends, & Scope
Chapter 4. Urinary Catheters Market: Product Estimates & Trend Analysis
Chapter 5. Urinary Catheters Market: Application Estimates & Trend Analysis
Chapter 6. Urinary Catheters Market: Type Estimates & Trend Analysis
Chapter 7. Urinary Catheters Market: Gender Estimates & Trend Analysis
Chapter 8. Urinary Catheters Market: End Use Estimates & Trend Analysis
Chapter 9. Urinary Catheters Market: Regional Estimates & Trend Analysis by Product, Application, Type, Gender, End Use
Chapter 10. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- BD
- Coloplast Corp
- B. Braun SE
- Medline Industries, LP.
- Hollister Incorporated
- Cook
- Teleflex Incorporated
- Optimum Medical Limited
- Convatec
- Boston Scientific Corporation
- Ur24Technology, Inc.
- Stryker
- InnoCare Urologics
- Boehringer Laboratories, LLC
- Consure Medical
- TillaCare Ltd.
- Medtronic
- Urotronic, Inc. (Laborie)
- Silq Technologies
- Cardinal Health
- Wellspect HealthCare, a Dentsply Sirona Company
- GHC German Health Care GmbH
- Sterimed Group
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 160 |
| Published | April 2026 |
| Forecast Period | 2025 - 2033 |
| Estimated Market Value ( USD | $ 6.54 Billion |
| Forecasted Market Value ( USD | $ 10.92 Billion |
| Compound Annual Growth Rate | 6.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
